Lac operon

From WikiMD's WELLNESSPEDIA

Lac operon is a genetic regulatory system found in Escherichia coli (E. coli) and some other bacteria. It consists of a series of genes which are responsible for the metabolism of lactose in these organisms. The lac operon was first described by François Jacob and Jacques Monod in 1961, who were awarded the Nobel Prize in Physiology or Medicine for their work in 1965.

Structure[edit]

The lac operon consists of three structural genes, and a promoter, a terminator, regulator, and an operator. The three structural genes are: lacZ, lacY, and lacA.

  • lacZ codes for beta-galactosidase, an enzyme that cleaves lactose into glucose and galactose.
  • lacY codes for permease, a protein that aids in the transport of lactose into the cell.
  • lacA codes for transacetylase, an enzyme that transfers an acetyl group from acetyl-CoA to beta-galactosides.

Regulation[edit]

The lac operon is regulated by several factors including the availability of glucose and lactose. It is an example of a negative control system because it is regulated by a repressor, the lacI gene product, which inhibits transcription. When lactose is present, it is converted into allolactose, which inhibits the repressor, allowing transcription to occur.

Induction and Repression[edit]

In the absence of lactose, the lac repressor binds to the operator region of the operon and prevents transcription of the downstream genes. When lactose is present, it binds to the repressor, causing a conformational change that makes it unable to bind to the operator. This is known as induction.

In the presence of glucose, the bacterium will suppress the lac operon to use the more energetically favorable glucose. This is known as catabolite repression.

Significance[edit]

The discovery of the lac operon has been fundamental to our understanding of gene regulation. It was the first genetic regulatory system to be understood in detail and has served as a model for the study of other genetic regulatory systems.

See also[edit]

This article is a stub related to biology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.